NEXT Oncology — Fairfax, Virginia

NEXT Oncology is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

NEXT Oncology has participated in 37 clinical trials with 30 currently active.

Therapeutic areas: Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).

Sponsors: Phanes Therapeutics, Janssen Research & Development, LLC, SystImmune Inc..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology?

NEXT Oncology has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology conducted?

NEXT Oncology has 37 clinical trials on record, with 30 currently active. Their work covers Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).

Is NEXT Oncology accredited by Crixeo Health?

Yes — NEXT Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.